Schisandrin B Preparation草藥製備
- Summary
- Schisandrin B is an extract from a Chinese medicine, which is well known of treating various cardiovascular diseases and many other conditions.
The invention reveals the method of preparation of Schisandrin B, and how to use it in prevention and/or treatment of heart diseases or other related conditions. Such preparation may additionally comprise one or more components selected from the group consisting of herbal extracts, fluids, solvents, antioxidants, preservatives, electrolytes, salts and pH control agents.
- Technology Benefits
- 1. Effective Extraction
2. Controlled concentration
3. Ready in various forms (aqueous, powdered, etc.)
- Technology Application
- - Applied in drugs
- Additives for foods, beverages
- Supplementary Information
- Patent Number: US7531195B2
Application Number: US200850136A
Inventor: Ko, Kam Ming
Priority Date: 22 Jul 2005
Priority Number: US7531195B2
Application Date: 17 Mar 2008
Publication Date: 12 May 2009
IPC Current: A61K003600
US Class: 424725
Assignee Applicant: The Hong Kong University of Science & Technology
Title: Schisandrin B preparation
Usefulness: Schisandrin B preparation
Summary: The composition is useful for preventing and/or treating conditions. The condition may be a heart condition, or a condition of some other organs e.g. liver, kidney or lung. The condition may be a cardiovascular condition, myocardial damage or infarction, coronary heart disease, impaired heart-lung function, cancer, heart failure, ischemia, viral myocarditis, septic/hemorrhagic shock, liver failure, chronic hepatitis, chronic bronchitis, gastritis, type II diabetes, toxic side effects arising from cancer chemotherapy, aging and age-related diseases such as liver and heart failure, Alzheimer's disease, Parkinson's disease, dehydration or failure of other organs. The condition may be muscle damage e.g. exercise induced muscle damage.
Novelty: Composition useful for preventing and/or treating diseases e.g. heart disorder, liver failure, schemia, viral myocarditis, septic and hemorrhagic shock, and chronic bronchitis, comprises Schisandrin B preparation
- Industry
- Disease Diagnostic/Treatment
- Sub Category
- Cancer/Tumor
- Application Date
- 17 Mar 2008
- Application No.
- US 12/050136
- Patent Information
- US 7531195
- ID No.
- TTC.PA.235S
- Country/Region
- Hong Kong
For more information, please click Here
